Enrich Biosystems

Branford, CT · Founded 2018 · Privately Held (backing)

Developer of a novel single-cell isolation technology designed to enhance biomedical research at a true single-cell level. Enrich Biosystems is based in Branford, CT and was founded in 2018. Its last reported valuation was $11.9 million in May 2022. It has raised $8.6 million across 3 recorded rounds; the latest was a $1.4 million debt round in Nov 2025.

Last reported valuation
$11.9M
Oct 2026
Priced at
—
Total raised
$8.6M
Last round
Debt
Nov 2025
What is Enrich Biosystems worth?
$11.9Mlast reported valuation · Oct 2026

Enrich Biosystems's last reported valuation, May 2022. Nothing priced has surfaced since.

Free account
More of Enrich Biosystems with a free account
  • ·The complete investor list: 15 names
  • ·Watch Enrich Biosystems: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Enrich Biosystems funding history

3 rounds
DateRoundRaisedPost-money
Nov 2025Debt$1.4M▮
May 2024Seed Round$2.2M▮
May 2024Seed Round$750K▮
Unlock post-money valuations

Membership and data by Private Market View

Enrich Biosystems valuation

Enrich Biosystems's last reported valuation was $11.9 million in May 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Enrich Biosystems raised?

Enrich Biosystems has raised $8.6 million across 3 recorded rounds since 2024. The largest was a $750,000 seed round in May 2024; the most recent was a $1.4 million debt round in Nov 2025.

Enrich Biosystems has filed 2 Form Ds with the SEC, most recently in May 2024 ($750,000 sold to 10 investors).

How Enrich Biosystems's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Enrich Biosystems, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Enrich Biosystems

What is Enrich Biosystems worth?
Enrich Biosystems is valued at $11.9M as of Oct 2026. Enrich Biosystems's last reported valuation, May 2022. Nothing priced has surfaced since.
How much has Enrich Biosystems raised?
Enrich Biosystems has raised $8.6M in total funding across 3 recorded rounds.
When did Enrich Biosystems last raise?
Enrich Biosystems last raised in Nov 2025 (Debt), raising $1.4M.